Prebashan Moodley
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 8
-
- Liver Disease and Transplantation 2
- Hepatitis Viruses Studies and Epidemiology 1
- Co-authors
- Ashwin Dhanda (4 shared papers)Huey Kuan Tan (1 shared paper)Juan Acevedo (1 shared paper)David A. Sheridan (1 shared paper)Sam Waddy (1 shared paper)Andrew Francis Whyte (1 shared paper)Matthew Cramp (1 shared paper)Daniel Jeffery Felmlee (1 shared paper)
- Journals
- The Lancet (7 papers)Nutrients (1 paper)Journal of Clinical Immunology (1 paper)Immunobiology (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- United KingdomBelgiumVietnam
In The Last Decade
Prebashan Moodley
14 papers receiving 3.2k citations
Prebashan Moodley's Hit Papers
Peers
Comparison fields: 5 of 105
- Infectious Diseases 2.4k
- Applied Microbiology and Biotechnology 40
- Internal Medicine 30
- Oncology 146
- Statistics and Probability 76
Countries citing papers authored by Prebashan Moodley
This map shows the geographic impact of Prebashan Moodley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prebashan Moodley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prebashan Moodley more than expected).
Fields of papers citing papers by Prebashan Moodley
This network shows the impact of papers produced by Prebashan Moodley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prebashan Moodley. The network helps show where Prebashan Moodley may publish in the future.
Co-authors
The 10 scholars most cited alongside Prebashan Moodley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 1531 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 6 | 2021 | 213 | |
| 7 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 8 | 2021 | 83 | |
| 9 | 2022 | 64 | |
| 10 | 2022 | 55 | |
| 11 | 2024 | 24 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 1 | |
| 14 | 2024 | 1 |
About Prebashan Moodley
Prebashan Moodley is a scholar working on Infectious Diseases, Hepatology, Gastroenterology, Pathology and Forensic Medicine and Immunology, having authored 14 papers that have together received 3.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Liver Disease and Transplantation (2 papers), Kawasaki Disease and Coronary Complications (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper), Alcohol Consumption and Health Effects (1 paper), Gastrointestinal motility and disorders (1 paper), Gut microbiota and health (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Infectious Diseases (2.4k citations), Applied Microbiology and Biotechnology (40 citations), Internal Medicine (30 citations), Oncology (146 citations) and Statistics and Probability (76 citations). Prebashan Moodley has collaborated with scholars based in United Kingdom, Belgium and Vietnam. Frequent co-authors include Ashwin Dhanda, Huey Kuan Tan, Juan Acevedo, David A. Sheridan, Sam Waddy, Andrew Francis Whyte, Matthew Cramp, Daniel Jeffery Felmlee, Joanne Hosking and Robert F. Tilley. Their work appears in journals such as The Lancet, Nutrients, Journal of Clinical Immunology, Immunobiology and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.